Biotage AB
Kungsgatan 76
Uppsala
SE-753 18
Tel: 46-18-56-59-00
Fax: 46-18-59-19-22
Website: http://www.biotage.com/
203 articles about Biotage AB
-
Astrea Bioseparations to Combine with Biotage AB, Creating Global Chromatography Leader
2/15/2023
Gamma Biosciences announced that it has entered into an agreement with Swedish life sciences company Biotage AB, whereby Biotage will acquire Gamma's operating company, Astrea Bioseparations, in exchange for newly issued shares in Biotage, creating a global chromatography leader with an attractive mix of products and services across multiple end-markets globally.
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Change in number of shares and votes in Biotage AB
12/30/2021
As previously announced, Biotage AB has during December 2021 issued 243,252 new class C shares in accordance with the incentive program LTIP 2021 which was adopted by the Annual General Meeting held on April 28, 2021.
-
New composition of Biotage Nomination Committee
12/13/2021
Following changes in ownership of Biotage AB, a new Nomination Committee consisting of members appointed by the three largest shareholders or group of shareholders and the Chairman of the Board of Directors has been formed for Biotage AB in accordance with the principles adopted by the annual general meeting held on 28 April 2021.
-
Biotage AB (publ) Interim report January - September 2021
10/28/2021
Biotage's profitable growth journey has continued in the third quarter with a new sales record and strong cash flow.
-
Biotage appoints Nomination Committee
10/25/2021
A Nomination Committee consisting of members appointed by the three largest shareholders or group of shareholders and the Chairman of the Board of Directors has been formed for Biotage AB in accordance with the principles adopted by the annual general meeting held on 28 April 2021 .
-
Biotage acquires ATDBio and strengthens its position in DNA and RNA Oligonucleotide synthesis and purification
10/20/2021
Biotage AB has entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited based in Oxford and Southampton, UK, for a total purchase price of approx.
-
Biotage AB (publ) Interim report January - June 2021
7/16/2021
Record quarterly net sales April–June Net sales amounted to SEK 303.5 (254.2) million, an increase of 19.4 percent and an organic* growth of 32.1 percent. The operating profit amounted to SEK 62.5 (24.5) million.
-
Biotage AB (publ) appoints new CFO - July 01, 2021
7/1/2021
Maja brings deep knowledge and experience from different functions within finance and management, in the life science industry.
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Biotage AB (publ) Interim report January - March 2021
4/28/2021
Double-digit organic growth in two consecutive quarters January - March Net sales amounted to 281.4 MSEK (277.3), an increase by 1.4 percent and organically* an increase by 12.0 percent. Operating profit amounted to 79.4 MSEK (61.4).
-
Resolutions at the Annual General Meeting in Biotage AB on April 28, 2021
4/28/2021
Biotage AB , on April 28, 2021, held its Annual General Meeting. Due to the extraordinary situation as a result of the Covid-19 pandemic, the Annual General Meeting was carried out through advance voting only, without any physical attendance.
-
NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ) - Mar 26, 2021
3/26/2021
The shareholders in Biotage AB, Reg. No. 556539-3138, with its registered office in Uppsala kommun, Uppsala län, are hereby summoned to the Annual General Meeting, to be held on Wednesday, 28 April 2021.
-
Biotage AB (publ) publishes its 2020 Annual Report, Corporate Governance Report and Remuneration Report
3/26/2021
Biotage's 2020 Annual Report, Corporate Governance Report and Remuneration Report are as of today available at: www.biotage.com This is information that Biotage AB (publ) is obliged to make public pursuant to the Securities Markets Act.
-
Biotage AB (publ) Year-End report January - December 2020
2/12/2021
Net sales amounted to 298.1 MSEK (288.6), an increase by 3.3 percent, and organically* an increase by 10.0 percent.
-
Biotage's Board of Directors does not intend to propose a dividend during the current year
11/4/2020
Biotage's Board of Directors has considered the issue to propose an Extraordinary General Meeting in 2020 to decide on a dividend. Due to continued uncertainty regarding the COVID-19-pandemic, the Board of Directors has decided not to convene an Extraordinary General Meeting during the current year to decide on a dividend. As u
-
Biotage appoints Nomination Committee - Sep 24, 2020
9/24/2020
A Nomination Committee consisting of members appointed by the three largest shareholders or group of shareholders and the Chairman of the Board of Directors has been formed for Biotage AB in accordance with the principles adopted by the annual general meeting held on 4 June 2020.
-
Biotage - change in number of shares and votes
8/31/2020
As previously announced, Biotage AB (publ) (Biotage) has during August 2020 issued 243,313 new class C shares in accordance with the incentive program LTIP 2020 which was adopted by the Annual General Meeting held on June 4, 2020 . Prior to the issue, the total number of outstanding shares and votes in Biotage amounted to 65,
-
Issue and re-purchase of class C shares for incentive program
8/18/2020
Biotage AB announced that, by virtue of the authorisation by the Annual General Meeting held on June 4, 2020, the Board of Directors has resolved to issue and immediately thereafter re-purchase 243,313 class C shares.
-
Biotage's Chairman of the Board has Sold Part of his Shares in Biotage - Remains as a Long-term Owner
4/30/2020
Torben Jørgensen, Chairman of the Board in Biotage AB, informed the company that he has sold part of his shareholding in Biotage on 29 April 2020.